4.5 Article

Conditional recurrence analysis of intrahepatic cholangiocarcinoma: Changes in recurrence rate and survival after recurrence resection by disease-free interval

Related references

Note: Only part of the references are listed.
Article Biotechnology & Applied Microbiology

Value of glycogen synthase 2 in intrahepatic cholangiocarcinoma prognosis assessment and its influence on the activity of cancer cells

A. Sigen et al.

Summary: Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver tumor with increasing incidence worldwide. The study revealed that low GYS2 expression in ICC predicted unfavorable patient outcomes, while GYS2 overexpression significantly impaired the proliferation, migration, and invasion of cholangiocarcinoma cells via activating the P53 pathway. GYS2 could become a potential therapeutic target for ICC patients.

BIOENGINEERED (2021)

Review Oncology

Recurrent Intrahepatic Cholangiocarcinoma - Review

Yuki Bekki et al.

Summary: Understanding the risk factors, patterns, and treatment options for intrahepatic cholangiocarcinoma recurrence is crucial for tailoring postoperative surveillance and selecting treatment strategies. Re-resection may be considered for selected patients at experienced centers, potentially leading to long-term survival. ICC remains a challenging disease, but advances in understanding its genomic landscape are paving the way for personalized treatment options.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

A New Surveillance Algorithm After Resection of Colorectal Liver Metastases Based on Changes in Recurrence Risk and RAS Mutation Status

Yoshikuni Kawaguchi et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)

Article Surgery

Treatment of recurrent intrahepatic cholangiocarcinoma

L. Sulpice et al.

BRITISH JOURNAL OF SURGERY (2012)

Article Surgery

One thousand fifty-six hepatectomies without mortality in 8 years

H Imamura et al.

ARCHIVES OF SURGERY (2003)